Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
4.680
+0.030 (0.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
Journey Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -18.34 | -3.85 | -29.63 | -43.99 | 5.28 | 3.63 |
| Depreciation & Amortization | 3.35 | 3.86 | 4.37 | 2.56 | 1.52 | 1.26 |
| Other Amortization | 0.22 | 0.36 | 0.06 | 2.57 | - | - |
| Asset Writedown & Restructuring Costs | - | 3.14 | - | 13.82 | - | - |
| Stock-Based Compensation | 5.25 | 2.61 | 4.43 | 2.47 | 0.15 | 0.24 |
| Provision & Write-off of Bad Debts | 0.77 | 0.44 | 0.28 | 0.05 | 0.05 | 0.1 |
| Other Operating Activities | -1.13 | 0.35 | 0.77 | 5.64 | 0.36 | 0.32 |
| Change in Accounts Receivable | -3.45 | 12.55 | -5.38 | 0.77 | -5.02 | -10.49 |
| Change in Inventory | -0.76 | 3.95 | 1.74 | -8.46 | -0.55 | -0.18 |
| Change in Accounts Payable | -12.83 | -18.42 | 14.34 | 20.39 | -0.15 | 1.15 |
| Change in Income Taxes | -0.13 | 0.02 | 0.03 | -0.09 | 2.19 | 1.02 |
| Change in Other Net Operating Assets | -0.82 | 0.24 | -4.55 | 2.1 | 1.3 | 11.97 |
| Operating Cash Flow | -27.87 | 5.24 | -13.53 | -2.18 | 5.13 | 9.02 |
| Operating Cash Flow Growth | - | - | - | - | -43.09% | - |
| Capital Expenditures | - | - | - | - | - | -2.4 |
| Sale (Purchase) of Intangibles | - | -5 | -20 | -10 | -1.2 | - |
| Investing Cash Flow | - | -5 | -20 | -10 | -1.2 | -2.4 |
| Short-Term Debt Issued | - | 28 | 5 | 7 | - | - |
| Long-Term Debt Issued | - | 15 | 19.76 | 9.54 | - | 0.45 |
| Total Debt Issued | 19.95 | 43 | 24.76 | 16.54 | - | 0.45 |
| Short-Term Debt Repaid | - | -30.95 | -2.86 | -6.19 | - | - |
| Long-Term Debt Repaid | - | -21.38 | -5 | -5.3 | -0.5 | -4 |
| Total Debt Repaid | -1.01 | -52.33 | -7.86 | -11.49 | -0.5 | -4 |
| Net Debt Issued (Repaid) | 18.95 | -9.33 | 16.9 | 5.05 | -0.5 | -3.55 |
| Issuance of Common Stock | 6.64 | 4.62 | 0.14 | 32.54 | 0.01 | - |
| Other Financing Activities | - | -0.09 | -0.59 | -3.55 | - | - |
| Financing Cash Flow | 25.58 | -4.8 | 16.46 | 53.02 | -0.49 | -3.55 |
| Net Cash Flow | -2.29 | -4.56 | -17.08 | 40.84 | 3.45 | 3.07 |
| Free Cash Flow | -27.87 | 5.24 | -13.53 | -2.18 | 5.13 | 6.62 |
| Free Cash Flow Growth | - | - | - | - | -22.45% | - |
| Free Cash Flow Margin | -48.25% | 6.62% | -18.37% | -3.45% | 11.52% | 18.95% |
| Free Cash Flow Per Share | -1.41 | 0.29 | -0.77 | -0.21 | 0.47 | 0.66 |
| Cash Interest Paid | 1.35 | 1.13 | 0.99 | - | - | - |
| Cash Income Tax Paid | 0.2 | 0.18 | 0.17 | 0.16 | 0.11 | 0.19 |
| Levered Free Cash Flow | -20.76 | -4.7 | -24.51 | -4.25 | 1.05 | - |
| Unlevered Free Cash Flow | -19.79 | -4 | -23.31 | -2.43 | 1.49 | - |
| Change in Net Working Capital | 17.13 | 6.13 | -5.1 | -14.32 | 3.89 | - |
Source: S&P Capital IQ. Standard template. Financial Sources.